| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |